A Non-Toxic Binuclear Vanadium(IV) Complex as Insulin Adjuvant Improves the Glycemic Control in Streptozotocin-Induced Diabetic Rats

Diabetes mellitus (DM) complications are a burden to health care systems due to the associated consequences of poor glycemic control and the side effects of insulin therapy. Recently. adjuvant therapies, such as vanadium compounds, have gained attention due to their potential to improve glucose home...

Full description

Bibliographic Details

Published in:	Pharmaceuticals
Main Authors:	Mateus S. Lopes, Gabriel B. Baptistella, Giovana G. Nunes, Matheus V. Ferreira, Joice Maria Cunha, Kauê Marcel de Oliveira, Alexandra Acco, Maria Luiza C. Lopes, Alexessander Couto Alves, Glaucio Valdameri, Vivian R. Moure, Geraldo Picheth, Graciele C. M. Manica, Fabiane G. M. Rego
Format:	Article
Language:	English
Published:	MDPI AG 2024-04-01
Subjects:	oxidovanadium(IV) vanadium STZ-induced diabetic rats adjunctive to insulin therapies treatment efficacy
Online Access:	https://www.mdpi.com/1424-8247/17/4/486